Analystreport

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its "buy" rating re-affirmed by analysts at Deutsche Bank AG. They now have a $255.00 price target on the stock.

Bio-Rad Laboratories, Inc. Class A  (BIO) 
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm Check Earnings Report